Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04871490
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-03-31
First Post:
2021-04-29
Brief Title:
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Study Overview
Official Title:
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IDEA-HPV
Brief Summary:
This study aims to determine whether a blood test for HPV DNA can improve diagnosis of HPV-positive oropharynx cancer HPV-OPC
Detailed Description:
The diagnosis of HPV-OPC is often delayed In this study individuals with signs or symptoms potentially related to HPV-OPC such as unexplained throat pain tonsil or tongue base asymmetry or a neck mass will have their blood tested for circulating HPV DNA A positive test may indicate that their symptoms are caused by HPV-OPC and their treating physician will be encouraged to complete all the necessary testing to determine whether this is the case
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None